WESTFIELD CAPITAL MANAGEMENT CO LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
WESTFIELD CAPITAL MANAGEMENT CO LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,985,325
-55.1%
1,386,058
-0.4%
0.11%
-56.5%
Q3 2022$31,177,000
-29.9%
1,391,217
-22.5%
0.25%
-29.1%
Q2 2022$44,461,000
-6.0%
1,794,248
+47.0%
0.35%
+15.5%
Q1 2022$47,312,000
+68.6%
1,220,321
+154.4%
0.30%
+81.4%
Q4 2021$28,064,000
+62.7%
479,648
+64.8%
0.17%
+60.6%
Q3 2021$17,254,000
-34.1%
291,101
-3.5%
0.10%
-33.8%
Q2 2021$26,180,000
+23.7%
301,651
+17.5%
0.16%
+18.9%
Q1 2021$21,166,000
+45.8%
256,717
+60.8%
0.13%
+53.5%
Q4 2020$14,516,000
-11.5%
159,639
-61.1%
0.09%
-18.9%
Q3 2020$16,401,000
+9.1%
410,329
-6.4%
0.11%
+2.9%
Q2 2020$15,039,000
+64.3%
438,323
+6.4%
0.10%
+27.2%
Q1 2020$9,153,000
-33.6%
412,096
-41.5%
0.08%
-17.3%
Q4 2019$13,794,000
-1.9%
704,843
-22.2%
0.10%
-13.3%
Q3 2019$14,064,000
-19.3%
905,619
+5.5%
0.11%
-13.7%
Q2 2019$17,433,000
+11.1%
858,749
-3.9%
0.13%
+10.1%
Q1 2019$15,697,000
+10.8%
893,425
-19.1%
0.12%
-1.7%
Q4 2018$14,168,000
+4.5%
1,104,305
+32.7%
0.12%
+27.4%
Q3 2018$13,554,000
+48.4%
832,070
+3.3%
0.10%
+39.7%
Q2 2018$9,134,000805,4600.07%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders